Acuitive Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ALLENDALE, N.J., March 13, 2023 (GLOBE NEWSWIRE) -- Acuitive Technologies announced that Vince Forlenza and Gary Fischetti will join their Board of...

First phase More than 100 researchers are working at Cúram at the moment as it nears the end of its first phase of development, which began when the centre was founded in 2015. Prof Pandit says that around 500 researchers will be needed as it moves into the second phase. “We will be ramping up hiring again in the next three to four months,” he predicts. Among the projects on which Cúram is working is a gel developed by US medical technology company Cerenovus to strengthen heart muscles after a heart attack. Prof Pandit explains that heart attacks weaken the muscle. Cerenovus i...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Acuitive Technologies Granted FDA 510(k) Clearance for CITREFIX™ Knotless Suture Anchor February 11, 2021 GMT ALLENDALE, N.J., Feb. 11, 2021 /PRNewswire/ -- Acuitive Technologies today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITREFIX™ Knotless Suture Anchor System with CITREGEN™ material technology, a new generation bioresorbable synthetic polymer. The CITREFIX system is intended to assist the attachment of tissue to bone during or...